Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:pharmaceuticals
|
| gptkbp:approves |
1951
|
| gptkbp:atccode |
A03 BB02
|
| gptkbp:brand |
gptkb:Buscopan
Colofac Spasmol |
| gptkbp:casnumber |
149-44-0
|
| gptkbp:chemical_formula |
C17 H22 Br N2 O4 S
|
| gptkbp:clinical_trial |
effective for IBS
not recommended for children under 6 reduces colicky pain well tolerated in adults |
| gptkbp:contraindication |
gptkb:Ophthalmology
gptkb:myasthenia_gravis urinary retention |
| gptkbp:excretion |
urine
feces |
| gptkbp:formulation |
gptkb:tablet
injection |
| https://www.w3.org/2000/01/rdf-schema#label |
Buscopan
|
| gptkbp:indication |
biliary colic
spasms of the gastrointestinal tract spasms of the urinary tract |
| gptkbp:ingredients |
hyoscine butylbromide
|
| gptkbp:interacts_with |
antihistamines
antidepressants antipsychotics muscle relaxants |
| gptkbp:legal_status |
prescription-only medication
|
| gptkbp:lifespan |
6 hours
|
| gptkbp:manufacturer |
gptkb:Boehringer_Ingelheim
|
| gptkbp:packaging |
blister pack
vial |
| gptkbp:pharmacokinetics |
peak plasma concentration in 1 hour
anticholinergic agent rapid absorption |
| gptkbp:route_of_administration |
oral
intravenous intramuscular |
| gptkbp:side_effect |
dizziness
constipation dry mouth blurred vision |
| gptkbp:storage |
keep out of reach of children
keep away from moisture store below 25° C |
| gptkbp:used_for |
abdominal pain
|
| gptkbp:weight |
404.33 g/mol
|
| gptkbp:bfsParent |
gptkb:scopolamine
|
| gptkbp:bfsLayer |
4
|